At a glance
- What the study gets you
- Access to the study treatment being tested
- Type of study
- Interventional (receives a drug or procedure)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Placebo (other), Magnesium hydroxide 375mg (supplement)
- How long the study runs
- Study runs about 12 months (dates as stated)
- About the drug or intervention
- Placebo — other: 12 week placebo supplement of 2 capsules per day · Magnesium hydroxide 375mg — supplement: 12 week supplementation of 2 capsules per day of Magnesium hydroxide
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Testing a treatment
- Ages
- 40 Years to 60 Years
- Who
- Female
- Number of participants
- 58
- Started
- 2025-12-09
- Last checked
- 2026-04
Plain English Summary
What is this study?
- • Testing a new treatment for perimenopause
- • NA - 58 participants
- • Perimenopause is a transition phase into menopause, characterised by menopausal symptoms while menstrual periods are still occurring
Who can take part?
- • Ages 40 Years to 60 Years
- • Diagnosed with perimenopause
- • Female only
Where?
- • Newcastle upon Tyne - School of Psychology, Northumbria University
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
Perimenopause is a transition phase into menopause, characterised by menopausal symptoms while menstrual periods are still occurring. Common symptoms of perimenopause include hot flushes, night sweats, mood swings, anxiety, sleep disturbances, fatigue, and cognitive difficulties. These symptoms can be both frequent and intense, with the potential to significantly deteriorate women's quality of life. Despite an increase in public discourse around menopause, there are still large gaps in knowledge. Previous literature has suggested a relationship between diet and menopause management. However, studies in this area are limited and women often rely on social media for advice on supplements to address menopause complaints. One supplement that has received a lot of attention with purported benefits for menopause is magnesium, primarily due to its links to energy and or/sleep, however no studies have explored psychological effects of magnesium supplementation in perimenopause. The aim of this study is to explore the effects of 12-weeks magnesium supplementation on perimenopause symptoms, cognition, sleep, and psychological well-being.
More detail
The term "perimenopause" describes a woman's life stage during which she undergoes changes due to hormone fluctuations but has not yet gone a full year without menstruation. It is a normal aspect of aging that typically affects women between the ages of 45 and 55, although some women may experience it sooner. While each person experiences symptoms differently, some common symptoms include irregular periods, hot flushes, night sweats, mood fluctuations, difficulty sleeping, decreased libido, vaginal dryness, memory and concentration problems. One widely recognised treatment for managing menopause symptoms is hormone replacement therapy (HRT). Although the benefits of HRT generally outweigh the risks, alternative options are needed for those with a history of breast cancer. Concerns surrounding risks have led many women to explore alternative approaches, including botanical and dietary supplements despite limited research on their efficacy and long-term effects. Women are increasingly turning to social media for advice on how to manage symptoms, and supplement manufacturers are beginning to target this audience with claims that they can reduce menopause symptoms. There is evidence of a link between nutrition and menopause, however research in this area is limited, especially in perimenopause. Magnesium is commonly promoted as a treatment for menopause symptoms, and there is some evidence that it improves sleep and overall well-being, but no research has looked into its effects in perimenopause. This study aims to examine the effects of 12-week magnesium hydroxide supplementation on cognition, sleep and psychological well-being in peri-menopausal women, with the results compared with those of a placebo.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 40 Years - 60 Years
- Who can join: Female only
What the study is looking for
- ✓Self-assess as healthy
- ✓Report experiencing troublesome peri-menopause symptoms in the past 6 months but not post-menopausal (defined as 12...
Who cannot take part
- ✗Post-menopausal
- ✗Lactating, pregnant or seeking to become pregnant
- ✗Nut Allergy
- ✗Taken antidepressant/antianxiety medication or other medication with strong likelihood for effects on cognition or...
- ✗Habitual magnesium supplementation (defined as more than 3 consecutive days or 4 days in total). Will be excluded...
See the full criteria
Where Is This Study? (1 UK site)
School of Psychology, Northumbria University
Newcastle upon Tyne NE1 8ST, United Kingdom